Expert Perspectives & Insights into CAR T-cell Therapy in Relapsed / Refractory Acute Lymphoblastic Leukemia - Episode 13
Treatment Approaches with Consolidation and Maintenance Post CAR T-cell Therapy
The panel examines their strategies for consolidation or maintenance treatment following CAR T-cell therapy, while also considering whether CAR T-cell therapy can function as a standalone treatment modality.
Video Player is loading.
Video content above is prompted by the following:
- What is your consolidation or maintenance treatment approach post CAR T-cell therapy? Can CAR T-cell therapy be a standalone therapy?
- How do high-risk features or extramedullary disease change your consolidation treatment strategy? What about those who are MRD-negative vs. MRD-positive post-CAR?